NCT03068221

Brief Summary

The Poly Cystic Ovary Syndrome (PCOS), is one of the most common reasons for subfertility, oligomenorrhea and amenorrhea. With the occurrence of 6-20% of the general adult women population. One of the main criteria of this syndrome is a hyper androgenic state. More than 50% of women who have PCOS are overweight. In the teenage population, PCOS is common in 5-10% of teenage girls. A recent research has shown that elite athlete teenage girls have higher serum androgen levels, especially in anaerobic types of sport. The purpose of this experiment is to examine the reaction of teenage PCOS overweight girls towards anaerobic exercise. To determine if their hyperandrogenic state is more adapted to excel in anaerobic exercise compared to teenage overweight girls without PCOS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 1, 2017

Completed
14 days until next milestone

Study Start

First participant enrolled

March 15, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

December 11, 2019

Status Verified

December 1, 2019

Enrollment Period

2.5 years

First QC Date

February 12, 2017

Last Update Submit

December 9, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Peak anaerobic power

    The highest produced power (Watt/Kg) during cycling at maximal speed against a weight based calculated resistance for 30 seconds

    30 seconds

  • Mean anaerobic power

    The mean produced power (Watt/Kg) during cycling at maximal speed against a weight based calculated resistance for 30 seconds

    30 seconds

Secondary Outcomes (1)

  • Total running time (Seconds) for a repeated sprint test.

    between 40-120 seconds

Study Arms (2)

Poly Cystic Ovary Syndrome

ACTIVE COMPARATOR

anaerobic exercise in overweight patients with PCOS

Other: anaerobic exercise

non Poly Cystic Ovary Syndrome

ACTIVE COMPARATOR

anaerobic exercise in overweight patients without PCOS

Other: anaerobic exercise

Interventions

assessing anaerobic exercise status

Poly Cystic Ovary Syndromenon Poly Cystic Ovary Syndrome

Eligibility Criteria

Age10 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • post menarche female
  • PCOS diagnosis
  • overweight- BMI above 85 percent.

You may not qualify if:

  • inability to complete the physical activity due to health issues
  • Thyroid dysfunction (hyper-, hypo-)
  • hyperprolactinemia
  • congenital adrenal hyperplasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center , Tel Aviv University

Kfar Saba, Israel

Location

MeSH Terms

Conditions

Polycystic Ovary SyndromeOverweight

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alon Elikaim, MD

    Meir Medical Center , Tel Aviv University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2017

First Posted

March 1, 2017

Study Start

March 15, 2017

Primary Completion

September 30, 2019

Study Completion

October 30, 2019

Last Updated

December 11, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations